allAfrica.com on MSN
Magoola's Dei Biopharma Develops Scalable Gene-Editing Tool for Sickle Cell Disease
The U.S. Patent and Trademark Office has accepted a groundbreaking patent from Dei BioPharma Ltd., marking a significant milestone in the treatment of sickle cell disease.Dei BioPharma, a Ugandan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results